In the News

Remdesivir, an antiviral drug tested against COVID-19 at UVA Health and other sites, appeared to improve survival rates and speed recovery times.

UVAToday

Two of the School of Medicine’s leading researchers are teaming to take on something that neither may have attempted on their own: the riddle of spinal cord injuries.

UVAToday

Curry School researchers believe a set of practices designed for classrooms can help families who are social distancing at home.

UVAToday

In the wake of the COVID-19 pandemic, UVA’s Center for Survey Research wants to help people and local agencies in Central Virginia get a better idea of what the future holds.

UVAToday

UVA computer science professor Madhav Marathe discusses the nuts and bolts of the new coronavirus tracking app that Apple and Google plan to roll out on smartphones next month.

UVAToday

UVA Health COO Wendy Horton said solutions to big problems – like a global pandemic – often start at academic medical centers.

UVAToday

Nursing professor Kathryn Laughon, who studies intimate partner violence, discusses how stay-at-home orders could affect domestic violence in the U.S and what can be done.

UVAToday

Two UVA psychologists discuss what staying isolated for so long can do to your body and your mind.

UVAToday